50 related articles for article (PubMed ID: 38683794)
1. Effects of Lobectomy versus Sub-Lobar Resection on the Survival in Adults with Stage IA Left Upper Lobe Non-Small Cell Lung Cancer: A Retrospective Cohort Study Based on the Surveillance, Epidemiology, and End Results Database.
Wen H; Liang C
Oncology; 2024; 102(6):525-532. PubMed ID: 37812916
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study.
Zhang Z; Huo H; Li F; Miao J; Hu B; Chen S
Thorac Cancer; 2024 May; 15(15):1218-1227. PubMed ID: 38606839
[TBL] [Abstract][Full Text] [Related]
3. Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.
Li Y; Wong M; Zhan L; Corke L; Brown MC; Cheng S; Khan K; Balatnaram K; Chowdhury M; Sabouhanian A; Herman J; Walia P; Strom E; Patel D; García-Pardo M; Schmid S; Eng L; Sacher AG; Leighl N; Bradbury PA; Shepherd FA; Shultz D; Liu G
Lung Cancer; 2024 Jun; 192():107823. PubMed ID: 38763103
[TBL] [Abstract][Full Text] [Related]
4. Application of unsupervised analysis techniques to lung cancer patient data.
Lynch CM; van Berkel VH; Frieboes HB
PLoS One; 2017; 12(9):e0184370. PubMed ID: 28910336
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
Shi Y; Wu S; Ma S; Lyu Y; Xu H; Deng L; Chen X
Ann Surg Oncol; 2022 Mar; 29(3):1868-1879. PubMed ID: 34613537
[TBL] [Abstract][Full Text] [Related]
6. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Meldola PF; Toth OAS; Schnorrenberger E; Machado PG; Chiarelli GFC; Kracik JLS; de Carvalho CC; Lôbo MM; Gross JL
Surg Oncol; 2023 Dec; 51():101995. PubMed ID: 37776757
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
[TBL] [Abstract][Full Text] [Related]
8. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
9. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
10. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
[TBL] [Abstract][Full Text] [Related]
11. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
12. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Moon MH; Moon YK; Moon SW
Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy or surgery for stage I-II non-small cell lung cancer treatment?-outcomes of a meta-analysis.
Zhang Q; Shao L; Tian J; Liu R; Geng Y; Liao Y; Luo H; Ge L; Feng S; Wang X; Yang Z
Transl Cancer Res; 2019 Aug; 8(4):1381-1394. PubMed ID: 35116881
[TBL] [Abstract][Full Text] [Related]
15. Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada M; Forbes H; Ashley S; Fenwick J
J Thorac Oncol; 2022 Apr; 17(4):532-543. PubMed ID: 35092841
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
